Search results
Results from the Health.Zone Content Network
The White House COVID-19 Response Team was the task force during the presidency of Joe Biden to respond to the COVID-19 pandemic in the United States. It was set up by Joe Biden on his first day in office [1] – January 20, 2021 – and replaced President Trump 's White House Coronavirus Task Force and Joe Biden 's transitional COVID-19 ...
Executive Order 13987, officially titled Organizing and Mobilizing the United States Government to Provide a Unified and Effective Response to Combat COVID-19 and to Provide United States Leadership on Global Health and Security, is the third executive order signed by the U.S. President Joe Biden on January 20, 2021. The order indicates that ...
Operation Warp Speed ( OWS) was a public–private partnership initiated by the United States government to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. [1] [2] The first news report of Operation Warp Speed was on April 29, 2020, [3] [4] [5] and the program was ...
On Monday, HHS announced the formation of the Office of Long COVID Research and Practice to lead the federal government’s response to long Covid, a sometimes-debilitating condition marked by ...
March 26, 2024 – The FDA has approved a new antibody treatment to help prevent COVID-19 in those who are most at risk from the virus. In its announcement, the agency explained that the new ...
The American Rescue Plan Act of 2021, also called the COVID-19 Stimulus Package or American Rescue Plan, is a US$1.9 trillion economic stimulus bill passed by the 117th United States Congress and signed into law by President Joe Biden on March 11, 2021, to speed up the country's recovery from the economic and health effects of the COVID-19 ...
Experts say adequate sleep and exercise are probably the best things someone with long-term COVID-19 symptoms can do. Filippo Bacci/Getty Images. Medical professionals are still assessing the ...
On March 30, HHS announced the first grant to a vaccine in development with $456 million allocated to Johnson & Johnson. Additional funds were approved for Moderna, AstraZeneca, Regeneron, Novavax, Pfizer, and a partnership between Sanofi and GlaxoSmithKline. The program's timeline was formally announced on May 15.